SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Est. Return 17.43%
This Quarter Est. Return
1 Year Est. Return
+17.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$144M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
73
New
Increased
Reduced
Closed

Top Buys

1
+$70M
2
+$49.3M
3
+$46.3M
4
LLY icon
Eli Lilly
LLY
+$34.5M
5
UTHR icon
United Therapeutics
UTHR
+$34.1M

Top Sells

1
+$111M
2
+$50.6M
3
+$47.6M
4
BPMC
Blueprint Medicines
BPMC
+$23.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$22.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
51
Wave Life Sciences
WVE
$1.14B
$766K 0.05%
+117,903
GPCR icon
52
Structure Therapeutics
GPCR
$1.52B
$712K 0.04%
34,353
-599
PRAX icon
53
Praxis Precision Medicines
PRAX
$4.33B
$661K 0.04%
15,717
-141,923
IMA
54
ImageneBio Inc
IMA
$89.5M
$513K 0.03%
31,885
IRON icon
55
Disc Medicine
IRON
$3.2B
$387K 0.02%
7,312
-173
ACAD icon
56
Acadia Pharmaceuticals
ACAD
$3.72B
– –
0
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$60.7B
– –
-176,181
BMY icon
58
Bristol-Myers Squibb
BMY
$89.2B
– –
-371,497
BPMC
59
DELISTED
Blueprint Medicines
BPMC
– –
-261,039
DHR icon
60
Danaher
DHR
$158B
– –
-58,606
ELVN icon
61
Enliven Therapeutics
ELVN
$1.22B
– –
-33,547
ERAS icon
62
Erasca
ERAS
$675M
– –
-1,877,085
IBB icon
63
iShares Biotechnology ETF
IBB
$6.21B
– –
0
INCY icon
64
Incyte
INCY
$17.8B
– –
-357,800
IWM icon
65
iShares Russell 2000 ETF
IWM
$71.6B
– –
0
KURA icon
66
Kura Oncology
KURA
$842M
– –
-791,667
MDT icon
67
Medtronic
MDT
$120B
– –
-562,992
PEN icon
68
Penumbra
PEN
$9.87B
– –
-42,936
QQQ icon
69
Invesco QQQ Trust
QQQ
$392B
– –
0
SMMT icon
70
Summit Therapeutics
SMMT
$14.4B
– –
0
SRPT icon
71
Sarepta Therapeutics
SRPT
$2.39B
– –
-327,618
SYK icon
72
Stryker
SYK
$146B
– –
-298,567
VIR icon
73
Vir Biotechnology
VIR
$831M
– –
-83,010
1 2
3